Back to top

brics: Archive

Andrew Rocco

3 Reasons Bitcoin's Momentum is just Beginning

Bitcoin is up 125% year-to-date versus the US Dollar. However, Stock Strategist Andrew Rocco explains why the momentum is just starting.

Andrew Rocco

A Golden Opportunity: 5 Reasons to Be Long Gold

Despite a decade of under-performance, gold is poised for a bull run. Five factors collectively suggest a promising outlook for gold, with the potential for a significant breakout in the near future.

Andrew Rocco

Diamonds in the Rough: 3 Chinese Stocks to Consider

It's no secret that China's economy has struggled in recent years. However, Stock Strategist Andrew Rocco sees opportunity amidst the chaos.

Sanghamitra Saha

Global Funds Bet Big on India Equities: Here's Why

Massive stimulus, normal Monsoon and government doles on rural India have been favoring India investing.

Urmimala Biswas

4 Sectors in Focus Following Coronavirus-Induced Selloff

While COVID-19 has dealt a huge blow to most sectors, it has opened up enormous opportunities for a few.

John Blank

Volatility Skyrockets: Global Week Ahead

Sure, central banks are slashing interest rates, but jump-starting the economic recovery might need large doses of government spending as well, in the form of tax breaks, infrastructure, welfare and so on.

John Blank

Coronavirus: How Does It Affect the Global Economy?

For the time being, becoming infected by the regular flu (Influenza) is far more likely in the U.S. ...and deadlier.

John Blank

A Struggle to Find Revenue Growth: Global Week Ahead

About 90% of S&P 500 companies have reported results as of Friday, Nov. 8th. 72.5% have beaten EPS estimates. Only 57.9% beat revenue estimates. A low Q3 revenue beat number (57.8%) is worrisome!

Zacks Equity Research

"Gesture of Good Will" Continues: 5 Strong Buys

As the United States and China exchange conciliatory gestures, trade war worries seem to ease. Buying these five stocks can glorify your portfolio.

Zacks Equity Research

Company News For Jul 31, 2019

Companies In The News Are: CMI, EME, SNE, XRX.